Clinical Laboratory Tests Market Analysis By Product (Complete Blood Count, HGB/HCT Tests, Basic Metabolic Panel, BUN Creatinine Tests, Electrolyte Testing, HbA1c Tests, Comprehensive Metabolic Panel, Liver Panel, Renal Panel, Lipid Panel) And Segment Forecasts To 2020
$4,700- April - 2015
- In Biotechnology
- By Grand View Research 1338 Views
The global market for clinical laboratory is expected to reach USD 148.82 billion by 2020, growing at an estimated CAGR of 6.8% from 2014 to 2020. Growing prevalence of chronic diseases and the development of novel laboratory testing methodologies is expected to drive the clinical laboratory tests market through to 2020. Due to the fact that results from clinical laboratory tests are the fundamental basis upon which medical practitioners and………………..
Total Pages: 99
clinical-laboratory-tests-market-analysis-product-complete-blood-count-hgbhct-tests-basic-metabolic-panel-bun-creatinine-tests-electrolyte-testing-hba1c-tests-comprehensive-metabolic-panel transparent 600 #9e2f22
The global market for clinical laboratory is expected to reach USD 148.82 billion by 2020, growing at an estimated CAGR of 6.8% from 2014 to 2020. Growing prevalence of chronic diseases and the development of novel laboratory testing methodologies is expected to drive the clinical laboratory tests market through to 2020. Due to the fact that results from clinical laboratory tests are the fundamental basis upon which medical practitioners and healthcare providers form their diagnosis and prognosis for the prevention and treatment for a range of diseases, clinical laboratory tests are critical to the global healthcare and medical fraternity. A growing global prevalence of medical conditions such as diabetes, obesity and other metabolic abnormalities coupled with increasing patient awareness levels is expected to boost market growth during the forecast period. Further key findings from the study suggest: Basic metabolic tests dominated the market in terms of market share in 2013 due to the fact that these are a panel of seven to eight tests which form the routine list of tests prescribed for almost all medical examinations. Due to the growing number of diabetic patients under treatment, it is also expected that the testing volumes for HbA1c tests will experience a productive growth in demand over the coming six years owing to their fundamental application in diabetic treatment monitoring. North America was observed to occupy the largest share of the market in 2013 and accounted for more than one third of the revenue generated in the clinical laboratory testing market. This large share can be attributed to the existence of a sophisticated healthcare framework and supportive reimbursement policy structure in the region. The Asia Pacific region is expected to grow at a lucrative rate throughout the forecast period due the development of clinical laboratory services and testing in the region. The presence of a large gap in supply and demand for clinical laboratory testing services in the emerging economies has also encouraged a shift in focus of the market leaders from the saturated North American and European regions to the developing markets of countries such as India and China. Key participants in the clinical laboratory tests market include Siemens Healthcare, Quest Diagnostics Inc., Sonic Healthcare Ltd., Bioscientia Healthcare, Abbott Laboratories, Charles River Laboratories, Bio-Reference Laboratories, Healthscope Limited., Labco S.A., Laboratory Corporation of America Holdings (Labcorp), ARUP Laboratories, Qiagen, Genoptix Medical Laboratory, Clarient Inc. and Genzyme Corporation. For the purpose of this study, Grand View Research has segmented the clinical laboratory tests market on the basis of test type, laboratory type and region: Global Clinical Laboratory Tests, Test Type Outlook (Revenue, USD Billion, 2012 – 2020) Complete Blood Count Market, by Laboratory Type Clinical Laboratory Tests Regional Outlook (Revenue, USD Billion, 2012 – 2020) North America Europe Asia Pacific RoW |